 
  
	内科理论与实践 ›› 2025, Vol. 20 ›› Issue (04): 267-271.doi: 10.16138/j.1673-6087.2025.04.01
• 专家论坛 • 下一篇
收稿日期:2024-11-20
									
				
									
				
									
				
											出版日期:2025-07-31
									
				
											发布日期:2025-10-27
									
			通讯作者:
					李慧凛 E-mail: 基金资助:Received:2024-11-20
									
				
									
				
									
				
											Online:2025-07-31
									
				
											Published:2025-10-27
									
			摘要:
风湿免疫性疾病常导致肾脏损害,临床表现形式多样且病情复杂,从轻微的蛋白尿到严重的肾小球肾炎,甚至肾功能衰竭,对患者预后和生活质量造成重大影响。由于肾损害往往起病隐匿,早期诊断和干预至关重要,开发无创生物标志物的需求十分迫切。该类疾病病理机制常涉及多系统,因此风湿科和肾脏科专家的多学科协作显得尤为重要。本文探讨了风湿免疫性疾病相关肾损害的发病机制、诊治策略,强调多学科合作在疾病管理中的重要性。随着新型靶向药物的开发应用和精准医学的发展,未来有望更好地控制疾病进展,保护肾功能并提高患者生活质量。
中图分类号:
李慧凛. 重视风湿免疫性疾病肾损害:诊治挑战与管理策略[J]. 内科理论与实践, 2025, 20(04): 267-271.
LI Huilin. Attention to renal damage in rheumatic autoimmune diseases: diagnostic challenges and management strategies[J]. Journal of Internal Medicine Concepts & Practice, 2025, 20(04): 267-271.
| [6] | Jamaly S, Rakaee M, Abdi R, et al. Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis[J]. Autoimmun Rev, 2021, 20:102980. | 
| [7] | Siegel CH, Sammaritano LR. Systemic lupus erythematosus[J]. JAMA, 2024, 331(17):1480-1491. | 
| [8] | Roveta A, Parodi EL, Brezzi B, et al. Lupus nephritis from pathogenesis to new therapies: An update[J]. Int J Mol Sci, 2024, 25(16):8981. | 
| [9] | Parums DV. A review of IgA vasculitis (henoch-schönlein purpura) past, present, and future[J]. Med Sci Monit, 2024, 30:e943912. | 
| [10] | Ponticelli C, Doria A, Moroni G. Renal disorders in rheumatologic diseases: the spectrum is changing (part 2. Arthridides)[J]. J Nephrol, 2021, 34(4):1081-1090. | 
| [11] | Bridoux F, Javaugue V, Nasr SH, et al. Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective[J]. Nephrol Dial Transplant, 2021, 36(2):208-215. | 
| [12] | Parisis D, Chivasso C, Perret J, et al. Current state of knowledge on primary Sjögren’s syndrome, an autoimmune exocrinopathy[J]. J Clin Med, 2020, 9(7):2299. | 
| [13] | Vaglio A, Gattorno M, McAdoo S, et al. The kidney in auto-immune and auto-inflammatory processes: definitions, mechanisms, and biomarkers[J]. Front Med (Lausanne), 2023, 9:1129021. | 
| [14] | Thurtle E, Grosjean A, Steenackers M, et al. Epidemiology of Sjögren’s: a systematic literature review[J]. Rheumatol Ther, 2024, 11(1):1-17. | 
| [15] | Cole A, Ong VH, Denton CP. Renal disease and systemic sclerosis: An update on scleroderma renal crisis[J]. Clin Rev Allergy Immunol, 2023, 64(3):378-391. | 
| [16] | Kamata Y, Sato H, Joh K, et al. Clinical characteristics of biopsy-proven renal sarcoidosis in Japan[J]. Sarcoidosis Vasc Diffuse Lung Dis, 2018, 35(3):252-260. | 
| [17] | Patriarcheas V, Tsamos G, Vasdeki D, et al. Antiphospholipid syndrome: A comprehensive clinical review[J]. J Clin Med, 2025, 14(3):733. | 
| [18] | Hamadeh M, Boustany S, Fares J. Acute kidney injury following dermatomyositis[J]. Clin Med Res, 2019, 17(3-4):102-104. doi: 10.3121/cmr.2019.1487 pmid: 31308024 | 
| [19] | Karam S, Haidous M, Royal V, et al. Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options[J]. Kidney Int, 2023, 103(3):473-484. | 
| [20] | Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective[J]. Biochem Pharmacol, 2020, 180:114147. | 
| [21] | Inker LA, Eneanya ND, Coresh J, et al. New creatinine- and cystatin c-based equations to estimate GFR without race[J]. N Engl J Med, 2021, 385(19):1737-1749. | 
| [22] | Alobaidi S, Alotaibi M, Al-Zahrani N, et al. Renal system and rheumatology[M]// Skills in rheumatology. Singapore: Springer, 2021:309-328. | 
| [23] | Sawamura M, Sawa N, Yamanouchi M, et al. Use of biologic agents and methotrexate improves renal manifestation and outcome in patients with rheumatoid arthritis: a retrospective analysis[J]. Clin Exp Nephrol, 2022, 26(4):341-349. | 
| [24] | Bruschi M, Candiano G, Petretto A, et al. Technology innovation for discovering renal autoantibodies in autoimmune conditions[J]. Int J Mol Sci, 2024, 25(23):12659. | 
| [1] | Hill AJ, Thomson RJ, Hunter JA, et al. The prevalence of chronic kidney disease in rheumatology outpatients[J]. Scott Med J, 2009, 54(2):9-12. | 
| [2] | Ponticelli C, Doria A, Moroni G. Renal disorders in rheumatologic diseases: the spectrum is changing (Part 1: connective tissue diseases)[J]. J Nephrol, 2021, 34(4):1069-1080. | 
| [3] | Kronbichler A, Mayer G. Renal involvement in autoimmune connective tissue diseases[J]. BMC Med, 2013, 11:95. doi: 10.1186/1741-7015-11-95 pmid: 23557013 | 
| [4] | Mok CC, So H, Hamijoyo L, et al. The 2024 APLAR consensus on the management of lupus nephritis[J]. Int J Rheum Dis, 2025, 28(1):e70021. | 
| [5] | Lichtnekert J, Anders HJ. Lupus nephritis-related chronic kidney disease[J]. Nat Rev Rheumatol, 2024, 20(11):699-711. doi: 10.1038/s41584-024-01158-w pmid: 39317803 | 
| [1] | 李雨航, 肖世富, 岳玲. 轻度行为损害与阿尔茨海默病相关研究的进展[J]. 诊断学理论与实践, 2025, 24(05): 548-554. | 
| [2] | 弓殷, 王学玲. 相关标志物及肠道微生物对结直肠癌肝转移的研究进展[J]. 内科理论与实践, 2025, 20(02): 178-182. | 
| [3] | 刘敬浩, 郭海艳, 甘桂芳, 陈福祥. miR-2355-3p、miR-337-3p和miR-99a-5p检测在头颈部鳞状细胞癌早期筛查中的价值[J]. 诊断学理论与实践, 2025, 24(02): 204-211. | 
| [4] | 曹璇君, 汤莹, 严敏曦. 多学科协作护理模式在唇腭裂序列治疗中的应用研究[J]. 组织工程与重建外科杂志, 2024, 20(2): 227-. | 
| [5] | 周悦, 叶媚娜, 代秋颖, 等. 肉芽肿性乳腺炎病灶组织差异表达蛋白质筛选及关键分子验证[J]. 组织工程与重建外科杂志, 2024, 20(1): 75-. | 
| [6] | 刘晏铭, 孙淑玉, 李嵩, 武剑. 系统性红斑狼疮合并钙质沉着症1例[J]. 内科理论与实践, 2024, 19(06): 409-412. | 
| [7] | 程昉, 赵福涛, 沈雪敏, 李瑾, 陈向军, 王桂芳, 李慧凛, 薛鸾, 齐军元. 原发性干燥综合征多学科诊疗专家共识(2024版)[J]. 内科理论与实践, 2024, 19(06): 357-362. | 
| [8] | 陈佳, 赵福涛, 孙建方. 皮肤病理学检查在风湿免疫性疾病诊断中的作用[J]. 内科理论与实践, 2024, 19(06): 367-371. | 
| [9] | 张煜, 查晴, 杨玲, 叶佳雯, 杨克, 刘艳. 血清MG53水平与冠状动脉钙化的相关性研究[J]. 内科理论与实践, 2024, 19(05): 303-309. | 
| [10] | 强士豪, 戴晴霞, 黄丽娜, 郭华, 崔小川. 慢性阻塞性肺疾病合并阻塞性睡眠呼吸暂停的生物标志物研究进展[J]. 内科理论与实践, 2024, 19(05): 322-327. | 
| [11] | 王虹晓, 苏琪莹, 阎骅. 结直肠癌预后生物标志物研究进展[J]. 内科理论与实践, 2024, 19(05): 337-341. | 
| [12] | 王一阳, 吕良敬. 系统性红斑狼疮CAR T细胞治疗疗效预测及安全性评估的潜在生物标志物[J]. 诊断学理论与实践, 2024, 23(03): 263-269. | 
| [13] | 王珏, 王佳琦, 陈珩, 等. 
	皮肤衰老相关的生物标志物及其作用机制的研究进展
[J]. 组织工程与重建外科杂志, 2023, 19(6): 586-. | 
| [14] | 赵晖,文柏清,康亚妮. 使用NanoString nCounter测定结直肠癌的潜在生物标志物[J]. J Shanghai Jiaotong Univ Sci, 2023, 28(4): 432-. | 
| [15] | 贾菁怡1,李正裔1, 2,彭琳晶1,姚怡飞1. 深部组织压力损伤的早期检测方法:系统综述[J]. J Shanghai Jiaotong Univ Sci, 2023, 28(4): 526-. | 
| 阅读次数 | ||||||
| 全文 |  | |||||
| 摘要 |  | |||||
